Trial Summary
What is the purpose of this trial?This clinical trial evaluates the feasibility of exercise during chemotherapy in older women with stage I-III breast cancer. Previous studies have reported that exercise may reduce the chemotherapy-toxicity risk. This trial may help researchers learn if engaging in a physical activity program is feasible in patients receiving chemotherapy for breast cancer.
Eligibility Criteria
This trial is for women aged 65 or older with Stage I-III breast cancer, about to start chemotherapy. They must be able to walk, do moderate exercise, and commit to the study's requirements. Women with serious medical conditions that prevent them from exercising cannot participate.Inclusion Criteria
Scheduled to begin adjuvant or neoadjuvant chemotherapy regimen either as standard-of-care or on study
English or Spanish speaking
Able to provide written, informed consent
+4 more
Exclusion Criteria
The presence of significant medical conditions that in the physician's judgement preclude participation in the exercise intervention
Participant Groups
The trial tests if it's practical for older women receiving chemotherapy for breast cancer to follow an exercise program. It includes questionnaires, discussions, using a medical device, quality-of-life assessments, and educational interventions about physical activity.
1Treatment groups
Experimental Treatment
Group I: Supportive care (coaching, exercise, questionnaire)Experimental Treatment6 Interventions
Patients participate in one-on-one coaching sessions with a health coach QW to discuss the content offered in the program, and challenges they are currently facing in achieving their exercise goals. Patients receive a copy of the WWE workbook, wear a fitness tracker and are encouraged to achieve 150 minutes of walking per week during chemotherapy and up to 1 month after chemotherapy. Patients also participate in the Growing Stronger Strength Training Program and receive instruction manuals. They perform the initial 2 exercises 2 days per week for 4 weeks, and subsequent 2 exercises 2 days per week for the remainder of the chemotherapy course. Patients maintain exercise logs and complete questionnaires over 30-45 minutes at baseline, end of chemotherapy and at 1 month after chemotherapy.
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
M D Anderson Cancer CenterHouston, TX
Loading ...
Who Is Running the Clinical Trial?
M.D. Anderson Cancer CenterLead Sponsor